Evidence map›Paper›PMID 25446987›Full record

ArticleBiochimica et biophysica acta2015

MALAT1 promotes colorectal cancer cell proliferation/migration/invasion via PRKA kinase anchor protein 9.

Min-Hui Yang, Zhi-Yan Hu, Chuan Xu, Lin-Ying Xie, Xiao-Yan Wang, Shi-You Chen, Zu-Guo Li

Open access · greenAbstract read
In one paragraph

Article in Biochimica et biophysica acta, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 121 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
121citing papers in PubMed, 6 pooled it
7.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

121 citing papers in PubMed, 6 syntheses or guidelines pooled it, 205 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Prognostic value of long non-coding RNA MALAT1 in cancer patients.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2016
    Pooled it
  6. Pooled it
  7. Review
  8. Fluorescence imaging of MALAT1 expression using a Cy5.5-labeled antisense oligonucleotide in lung cancer and epidermal carcinoma cells.Cancer imaging : the official publication of the International Cancer Imaging Society · 2025
    Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Genes · 2024
    Review
  15. Review
  16. Review
  17. Article
  18. Expression ofInternational journal of molecular sciences · 2024
    Article
  19. Article
  20. Article

61 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Min-Hui YangDepartment of Pathology, Nanfang Hospital, Southern Medical University, China; Key Laboratory of Transcriptome and Proteome for Human Major Diseases of the Ministry of Education and Guangdong Province, Guangzhou 510515, Guangdong Province, China.
Zhi-Yan HuDepartment of Pathology, Nanfang Hospital, Southern Medical University, China; Key Laboratory of Transcriptome and Proteome for Human Major Diseases of the Ministry of Education and Guangdong Province, Guangzhou 510515, Guangdong Province, China.
Chuan XuDepartment of Pathology, Nanfang Hospital, Southern Medical University, China; Key Laboratory of Transcriptome and Proteome for Human Major Diseases of the Ministry of Education and Guangdong Province, Guangzhou 510515, Guangdong Province, China.
Lin-Ying XieDepartment of Pathology, Nanfang Hospital, Southern Medical University, China; Key Laboratory of Transcriptome and Proteome for Human Major Diseases of the Ministry of Education and Guangdong Province, Guangzhou 510515, Guangdong Province, China.
Xiao-Yan WangDepartment of Pathology, Nanfang Hospital, Southern Medical University, China; Key Laboratory of Transcriptome and Proteome for Human Major Diseases of the Ministry of Education and Guangdong Province, Guangzhou 510515, Guangdong Province, China.
Shi-You ChenDepartment of Physiology & Pharmacology, University of Georgia, Athens, GA, USA. Electronic address: sc229@uga.edu.
Zu-Guo LiDepartment of Pathology, Nanfang Hospital, Southern Medical University, China; Key Laboratory of Transcriptome and Proteome for Human Major Diseases of the Ministry of Education and Guangdong Province, Guangzhou 510515, Guangdong Province, China. Electronic address: Lizg@smu.edu.cn.
Nanfang Hospital · CNUniversity of Georgia · US

Funding

Novel mechanism of smooth muscle phenotypic modulation and vascular remodelingR01HL119053 · NHLBI · UNIVERSITY OF MISSOURI-COLUMBIA · PI CHEN, SHIYOU · 2014 to 2023
$3.8M
Dedicator of Cytokinesis 2 in smooth muscle phenotype modulationR01HL123302 · NHLBI · UNIVERSITY OF MISSOURI-COLUMBIA · PI CHEN, SHIYOU · 2014 to 2018
$1.8M
Smooth Muscle Differentiation and MaturationR01HL107526 · NHLBI · UNIVERSITY OF GEORGIA · PI CHEN, SHIYOU · 2011 to 2014
$1.5M
NHLBI NIH HHS R01 HL107526NHLBI NIH HHS R01 HL119053NHLBI NIH HHS R01 HL123302
6 · The paper itself

Abstract

Our previous studies have shown that the 3' end of metastasis associated lung adenocarcinoma transcript 1 (MALAT1) is involved in colorectal cancer (CRC) cell proliferation and migration/invasion in vitro. The role and mechanism of MALAT1 in CRC metastasis in vivo, however, remain largely unknown. In the present study, we found that MALAT1 was up-regulated in human primary CRC tissues with lymph node metastasis. Overexpression of MALAT1 via RNA activation promoted CRC cell proliferation, invasion and migration in vitro, and stimulated tumor growth and metastasis in mice in vivo. Conversely, knockdown of MALAT1 inhibited CRC tumor growth and metastasis. MALAT1 regulated at least 243 genes in CRC cells in a genome-wide expression profiling. Among these genes, PRKA kinase anchor protein 9 (AKAP-9) was significantly up-regulated at both mRNA and protein levels. AKAP-9 was highly expressed in CRC cells with metastatic potential and human primary CRC tissues with lymph node metastasis, but not in normal cells or tissues. Importantly, knockdown of AKAP-9 blocked MALAT1-mediated CRC cell proliferation, migration and invasion. These data indicate that MALAT1 may promote CRC tumor development via its target protein AKAP-9.

Indexed as

Cell ProliferationLymphatic MetastasisNeoplasm InvasivenessA Kinase Anchor ProteinsBlotting, WesternCell Line, TumorColorectal NeoplasmsCytoskeletal ProteinsHumansOligonucleotide Array Sequence AnalysisRNA, Long NoncodingSpectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationAKAP9 protein, humanA Kinase Anchor ProteinsCytoskeletal ProteinsMALAT1 long non-coding RNA, humanRNA, Long NoncodingColorectal cancerLong non-coding RNAMetastasisMetastasis associated lung adenocarcinoma transcript 1PRKA kinase anchor protein 9

Identifiers

PMID25446987
PMCPMC4268411
OpenAlexW2147287621

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.